Long term results of total hip arthroplasty with cemented and cementless tapered femoral component.
Surgery, survival, long-term outcomes
Taperloc
Total hip arthroplasties
Journal
SICOT-J
ISSN: 2426-8887
Titre abrégé: SICOT J
Pays: France
ID NLM: 101675099
Informations de publication
Date de publication:
2023
2023
Historique:
received:
01
12
2022
accepted:
07
05
2023
medline:
6
6
2023
pubmed:
6
6
2023
entrez:
6
6
2023
Statut:
ppublish
Résumé
Excellent midterm results for total hip arthroplasties (THA) with cementless, tapered porous Taperloc To evaluate the long-term outcomes of both cemented and cementless THAs with the Taperloc femoral component. The medical records of 71 patients (76 hips), operated on between January 1991 and December 2003, who had a minimum follow-up of 10 years were available for analysis. Functional analysis was performed with the Harris hip score (HHS) questionnaire and the numerical analogue scale (NAS). Radiographic analysis was performed for subsidence, radiolucent lines and osteolysis. The cohort was comprised of 47 female and 24 male patients, with a mean age of 59.7 ± 12.4 years. The mean follow-up was 17.8 ± 4.4 years. 52.6% of THAs analyzed were cementless and 47.4% were cemented. Post-operative radiographs were available for 57 surgeries. Subsidence, hypertrophic ossification, radiolucent lines and osteolysis were noted in 4 (7%), 2 (2.6%), 14 (18.4%) and 11 (14.5%) hips respectively. The average HHS score at a mean follow-up of 20.1 ± 3.9 years was 62.1 (±27.7) and the NAS score was 4.6 (±3.6). During the study period, five revision surgeries were performed due to stem-related problems, one of which was for aseptic loosening. Our long-term experience with the Taperloc stem, both cemented and cementless, demonstrates good outcomes, with low rates of failure. This makes this prosthesis an attractive option for THAs. IV.
Sections du résumé
BACKGROUND
BACKGROUND
Excellent midterm results for total hip arthroplasties (THA) with cementless, tapered porous Taperloc
OBJECTIVES
OBJECTIVE
To evaluate the long-term outcomes of both cemented and cementless THAs with the Taperloc femoral component.
METHODS
METHODS
The medical records of 71 patients (76 hips), operated on between January 1991 and December 2003, who had a minimum follow-up of 10 years were available for analysis. Functional analysis was performed with the Harris hip score (HHS) questionnaire and the numerical analogue scale (NAS). Radiographic analysis was performed for subsidence, radiolucent lines and osteolysis.
RESULTS
RESULTS
The cohort was comprised of 47 female and 24 male patients, with a mean age of 59.7 ± 12.4 years. The mean follow-up was 17.8 ± 4.4 years. 52.6% of THAs analyzed were cementless and 47.4% were cemented. Post-operative radiographs were available for 57 surgeries. Subsidence, hypertrophic ossification, radiolucent lines and osteolysis were noted in 4 (7%), 2 (2.6%), 14 (18.4%) and 11 (14.5%) hips respectively. The average HHS score at a mean follow-up of 20.1 ± 3.9 years was 62.1 (±27.7) and the NAS score was 4.6 (±3.6). During the study period, five revision surgeries were performed due to stem-related problems, one of which was for aseptic loosening.
CONCLUSIONS
CONCLUSIONS
Our long-term experience with the Taperloc stem, both cemented and cementless, demonstrates good outcomes, with low rates of failure. This makes this prosthesis an attractive option for THAs.
LEVEL OF EVIDENCE
METHODS
IV.
Identifiants
pubmed: 37278510
doi: 10.1051/sicotj/2023014
pii: sicotj220102
pmc: PMC10243125
doi:
Types de publication
Journal Article
Langues
eng
Pagination
17Informations de copyright
© The Authors, published by EDP Sciences, 2023.
Références
J Arthroplasty. 2016 Jun;31(6):1275-1278
pubmed: 26781396
J Bone Joint Surg Am. 2015 Sep 2;97(17):1386-97
pubmed: 26333733
EFORT Open Rev. 2017 Mar 13;1(5):197-204
pubmed: 28461948
Acta Orthop. 2011 Apr;82(2):143-8
pubmed: 21463220
Lancet. 2007 Oct 27;370(9597):1508-19
pubmed: 17964352
J Bone Joint Surg Am. 2002 Oct;84(10):1823-8
pubmed: 12377914
SICOT J. 2020;6:15
pubmed: 32500856
Clin Orthop Relat Res. 2011 Jan;469(1):209-17
pubmed: 20625950
J Bone Joint Surg Am. 2001 Mar;83(3):359-63
pubmed: 11263639
Clin Orthop Relat Res. 1990 Aug;(257):107-28
pubmed: 2199114
SICOT J. 2021;7:26
pubmed: 33843582
Clin Orthop Relat Res. 2001 Dec;(393):121-7
pubmed: 11764340
Ortop Traumatol Rehabil. 2016 Aug 30;18(4):317-325
pubmed: 28102164
Acta Orthop Belg. 2000 Dec;66(5):472-6
pubmed: 11196371
J Bone Joint Surg Am. 1969 Jun;51(4):737-55
pubmed: 5783851
J Bone Joint Surg Am. 2008 Jun;90(6):1290-6
pubmed: 18519323
J Bone Joint Surg Br. 2007 Dec;89(12):1574-80
pubmed: 18057355
Acta Orthop Belg. 2002 Feb;68(1):33-6
pubmed: 11915456
SICOT J. 2018;4:4
pubmed: 29469804
J Bone Joint Surg Am. 2015 Feb 4;97(3):186-93
pubmed: 25653318
Orthopedics. 2010 Sep 07;33(9):639
pubmed: 20839681
PLoS One. 2013 Sep 04;8(9):e73228
pubmed: 24023837
J Arthroplasty. 2004 Feb;19(2):151-6
pubmed: 14973856